HomeTagsNCT05938023

NCT05938023

Popular

Must Read

About us

We do not want children to die from a disease that can be cured. We want to give hope to families and ensure that all children with DMD are treated and regain their health.

Latest Articles

Del-zota (EXPLORE44) Provides Nearly 30% Normal Dystrophin Production in Patients Amenable to Exon 44 Skipping

Editorials 0
A phase 1/2 EXPLORE44 study (NCT05670730) is now being...

Belief BioMed BBM-D101 Gene Therapy Receives IND Clearance by National Medical Products Administration (NMPA)

Press Releases 0
Belief BioMed (BBM), an innovative biotechnology company focused on...

Dr. Aravindhan Veerapandiyan, a neurologist at Arkansas Children’s Hospital, Reviews RGX-202 Gene Therapy Study

Editorials 0
At the American Academy of Neurology Annual Meeting, which...

Most Popular

Frequently Asked Questions About Elevidys Used for Duchenne Muscular Dystrophy

Approved Treatments 5
A genetic condition known as Duchenne muscular dystrophy (DMD)...

What is Duvyzat (Givinostat)?

Approved Treatments 1
For individuals with Duchenne muscular dystrophy (DMD), adults and...

In Which Countries Is Elevidys Approved? Is Elevidys Approved In Europe?

Editorials 0
Elevidys is the only approved gene therapy in the...

© 2024 - 2025 DMD Warrior. All rights reserved.